Company profile for Eclipse Bioinnovations

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Eclipsebio is at the forefront of developing first-in-class technologies, analyses, and platforms for RNA-based and RNA-targeting therapies. Leveraging our extensive experience in supporting early-stage basic research and evaluating preclinical vaccines and gene therapies, we provide exceptional insights into RNA and therapeutic biology. Our solutions are designed as comprehensive end-to-end partnerships, including custom assa...
Eclipsebio is at the forefront of developing first-in-class technologies, analyses, and platforms for RNA-based and RNA-targeting therapies. Leveraging our extensive experience in supporting early-stage basic research and evaluating preclinical vaccines and gene therapies, we provide exceptional insights into RNA and therapeutic biology. Our solutions are designed as comprehensive end-to-end partnerships, including custom assay development, tailored to meet the needs of biopharma and biotech companies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
5770 Oberlin Dr, San Diego, California 92121
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty